Author Llorens, Franc

• 2013 | Journal Article
  ​ ​PrP mRNA and protein expression in brain and PrPc in CSF in Creutzfeldt-Jakob disease MM1 and VV2​
  Llorens, F.; Ansoleaga, B.; Garcia-Esparcia, P.; Zafar, S.; Grau-Rivera, O.; Lopez-Gonzalez, I. & Blanco, R. et al.​ (2013) 
  Prion, 7(5) pp. 383​-393​.​ DOI: https://doi.org/10.4161/pri.26416 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Conference Abstract
  ​ ​Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease​
  Llorens, F.; Zafar, S.; Ansoleaga, B.; Shafiq, M. ; Blanco, R.; Carmona, M. & Gelpi, E. et al.​ (2014)
  Prion, 8 
  Austin​: Landes Bioscience.
  ​Details  WoS 

• 2014 | Journal Article | 
  ​ ​Subtype and regional-specific neuroinflammation in sporadic Creutzfeldt-Jakob disease​
  Llorens, F.; Lopez-Gonzalez, I.; Thuene, K.; Carmona, M.; Zafar, S.; Andreoletti, O. & Zerr, I. et al.​ (2014) 
  Frontiers in Aging Neuroscience, 6 art. 198​.​ DOI: https://doi.org/10.3389/fnagi.2014.00198 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease​
  Llorens, F.; Zafar, S. ; Ansoleaga, B.; Shafiq, M.; Blanco, R.; Carmona, M. & Grau-Rivera, O. et al.​ (2015) 
  Neuropathology and Applied Neurobiology, 41(5) pp. 631​-645​.​ DOI: https://doi.org/10.1111/nan.12175 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Increased albumin CSF/serum ratio in dementia with Lewy bodies​
  Llorens, F.; Schmitz, M.; Gloeckner, S. F.; Kaerst, L.; Hermann, P.; Schmidt, C. D. & Varges, D. A. et al.​ (2015) 
  Journal of the Neurological Sciences, 358(1-2) pp. 398​-403​.​ DOI: https://doi.org/10.1016/j.jns.2015.10.011 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD​
  Llorens, F.; Kruse, N.; Schmitz, M.; Shafiq, M.; Gomes da Cunha, J. E.; Gotzman, N.   & Zafar, S. et al.​ (2015) 
  Journal of Neurology, 262(10) pp. 2305​-2311​.​ DOI: https://doi.org/10.1007/s00415-015-7837-x 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Application of capillary immunoelectrophoresis revealed an age- and gender-dependent regulated expression of PrPC in liver​
  Arora, A. S. ; Zafar, S.; Kollmar, O.; Llorens, F.; Tahir, W.; Vanselow, S. & Kumar, P. et al.​ (2015) 
  Electrophoresis, 36(24) pp. 3026​-3033​.​ DOI: https://doi.org/10.1002/elps.201500244 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Creutzfeldt-Jakob Disease Subtype-Specific Regional and Temporal Regulation of ADP Ribosylation Factor-1-Dependent Rho/MLC Pathway at Pre-Clinical Stage​
  Zafar, S.; Schmitz, M.; Younus, N.; Tahir, W.; Shafiq, M.; Llorens, F. & Ferrer, I. et al.​ (2015) 
  Journal of Molecular Neuroscience, 56(2) pp. 329​-348​.​ DOI: https://doi.org/10.1007/s12031-015-0544-3 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article | 
  ​ ​Involvement of PrP(C) in kainate-induced excitotoxicity in several mouse strains.​
  Carulla, P.; Llorens, F.; Matamoros-Angles, A.; Aguilar-Calvo, P.; Espinosa, J. C.; Gavín, R. & Ferrer, I. et al.​ (2015) 
  Scientific reports, 5 art. 11971​.​ DOI: https://doi.org/10.1038/srep11971 
  ​Details  DOI  PMID  PMC 

• 2015 | Journal Article
  ​ ​Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy​
  Schmitz, M.; Hermann, P.; Oikonomou, P.; Stoeck, K.; Ebert, E.; Poliakova, T. & Schmidt, C. D. et al.​ (2015) 
  Neurobiology of Aging, 36(9) pp. 2597​-2606​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2015.05.013 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​Altered Mitochondria, Protein Synthesis Machinery, and Purine Metabolism Are Molecular Contributors to the Pathogenesis of Creutzfeldt-Jakob Disease​
  Ansoleaga, B.; Garcia-Esparcia, P.; Llorens, F.; Hernandez-Ortega, K.; Carmona, M.; Antonio del Rio, J. & Zerr, I. et al.​ (2016) 
  Journal of Neuropathology & Experimental Neurology, 75(8) pp. 755​-769​.​ DOI: https://doi.org/10.1093/jnen/nlw048 
  ​Details  DOI  WoS 

• 2016 | Conference Abstract
  ​ ​Identification of new molecular alterations in Fatal Familial Insomnia​
  Ferrer, I.; Llorens, F.; Frau-Mendez, L.; Fernandez-Vega, I.; Thune, K.; Antonio del Rio, J. & Schmizt, M. et al.​ (2016)
  Prion, 10 
  Philadelphia​: Taylor & Francis Inc.
  ​Details  WoS 

• 2016 | Journal Article
  ​ ​Identification of new molecular alterations in Fatal Familial Insomnia (vol 10, pg S83, 2016)​
  Ferrer, I.; Llorens, F.; Frau-Mendez, L.; Fernandez-Vega, I.; Thüne, K.; Antonio del Rio, J. & Schmitz, M. et al.​ (2016) 
  Prion, 10(4).​ DOI: https://doi.org/10.1093/hmg/ddw108 
  ​Details  DOI  WoS 

• 2016 | Conference Abstract
  ​ ​Genetic prion diseases​
  Zerr, I.; Schmitz, M.; Zafar, S. & Llorens, F.​ (2016)
  Prion, 10 
  Philadelphia​: Taylor & Francis Inc.
  ​Details  WoS 

• 2016 | Journal Article
  ​ ​Progress in CSF biomarker discovery in sCJD​
  Llorens, F.; Schmitz, M. & Zerr, I.​ (2016) 
  Oncotarget, 8(4) pp. 5666​-5667​.​ DOI: https://doi.org/10.18632/oncotarget.13998 
  ​Details  DOI 

• 2016 | Journal Article
  ​ ​Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia​
  Llorens, F.; Schmitz, M.; Karch, A.; Cramm, M.; Lange, P.; Gherib, K. & Varges, D. A. et al.​ (2016) 
  Alzheimer s & Dementia, 12(5) pp. 577​-589​.​ DOI: https://doi.org/10.1016/j.jalz.2015.10.009 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article | 
  ​ ​Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients​
  Schmitz, M.; Llorens, F.; Pracht, A.; Thom, T.; Correia, A. ; Zafar, S. & Ferrer, I. et al.​ (2016) 
  Aging, 8(11) pp. 2927​-2935​.​ DOI: https://doi.org/10.18632/aging.101101 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Review
  ​ ​CSF biomarkers in neurodegenerative and vascular dementias​
  Llorens, F.; Schmitz, M.; Ferrer, I.& Zerr, I.​ (2016)
  Progress in Neurobiology, 138​ pp. 36​-53​.​
  Pergamon-elsevier Science Ltd. DOI: https://doi.org/10.1016/j.pneurobio.2016.03.003 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic​
  Schmitz, M.; Ebert, E.; Stoeck, K.; Karch, A.; Collins, S. J.; Calero, M. & Sklaviadis, T. et al.​ (2016) 
  Molecular Neurobiology, 53(4) pp. 2189​-2199​.​ DOI: https://doi.org/10.1007/s12035-015-9167-5 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​Cerebrospinal alpha-synuclein in alpha-synuclein aggregation disorders: tau/alpha-synuclein ratio as potential biomarker for dementia with Lewy bodies​
  Llorens, F.; Schmitz, M.; Varges, D. A.; Kruse, N.; Gotzmann, N.; Gmitterova, K. & Mollenhauer, B. et al.​ (2016) 
  Journal of Neurology, 263(11) pp. 2271​-2277​.​ DOI: https://doi.org/10.1007/s00415-016-8259-0 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​Identification of new molecular alterations in fatal familial insomnia​
  Llorens, F.; Thuene, K.; Schmitz, M.; Ansoleaga, B.; Frau-Mendez, M. A.; Cramm, M. & Tahir, W. et al.​ (2016) 
  Human Molecular Genetics, 25(12) pp. 2417​-2436​.​ DOI: https://doi.org/10.1093/hmg/ddw108 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​Mitochondrial DNA differentiates Alzheimer's disease from Creutzfeldt-Jakob disease​
  Podlesniy, P.; Llorens, F.; Golanska, E.; Sikorska, B.; Liberski, P. P.; Zerr, I. & Trullas, R.​ (2016) 
  Alzheimer s & Dementia, 12(5) pp. 546​-555​.​ DOI: https://doi.org/10.1016/j.jalz.2015.12.011 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article | 
  ​ ​Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie​
  Schmitz, M.; Cramm, M.; Llorens, F.; Candelise, N. ; Mueller-Cramm, D.; Varges, D. A. & Schulz-Schaeffer, W. J. et al.​ (2016) 
  Scientific Reports, 6 art. 28711​.​ DOI: https://doi.org/10.1038/srep28711 
  ​Details  DOI  PMID  PMC  WoS 

• 2017 | Journal Article | 
  ​ ​YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias​
  Llorens, F.; Thüne, K.; Tahir, W.; Kanata, E.; Diaz-Lucena, D.; Xanthopoulos, K. & Kovatsi, E. et al.​ (2017) 
  Molecular Neurodegeneration, 12(1) art. 83​.​ DOI: https://doi.org/10.1186/s13024-017-0226-4 
  ​Details  DOI 

• 2017 | Journal Article
  ​ ​Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs​
  Llorens, F.; Karch, A.; Golanska, E.; Schmitz, M.; Lange, P.; Sikorska, B. & Liberski, P. P. et al.​ (2017) 
  Dementia and Geriatric Cognitive Disorders, 43(1-2) pp. 71​-80​.​ DOI: https://doi.org/10.1159/000454802 
  ​Details  DOI  PMID  PMC  WoS 

• 2017 | Journal Article | 
  ​ ​Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms.​
  Garcia-Esparcia, P.; López-González, I.; Grau-Rivera, O.; García-Garrido, M. F.; Konetti, A.; Llorens, F. & Zafar, S. et al.​ (2017) 
  Frontiers in neurology, 8 art. 89​.​ DOI: https://doi.org/10.3389/fneur.2017.00089 
  ​Details  DOI  PMID  PMC 

• 2018 | Journal Article
  ​ ​Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases​
  Villar-Piqué, A.; Schmitz, M.; Lachmann, I.; Karch, A.; Calero, O.; Stehmann, C. & Sarros, S. et al.​ (2018) 
  Molecular Neurobiology, 56(4) pp. 2811​-2821​.​ DOI: https://doi.org/10.1007/s12035-018-1251-1 
  ​Details  DOI 

• 2018 | Book Chapter
  ​ ​Cerebrospinal fluid in Creutzfeldt–Jakob disease​
  Zerr, I.; Zafar, S.; Schmitz, M.& Llorens, F.​ (2018)
  In: Cerebrospinal Fluid in Neurologic Disorders pp. 115​-124. ​Elsevier. DOI: https://doi.org/10.1016/B978-0-12-804279-3.00008-3 
  ​Details  DOI 

• 2018 | Book Chapter
  ​ ​Amplification and Detection of Minuscule Amounts of Misfolded Prion Protein by Using the Real-Time Quaking-Induced Conversion​
  Schmitz, M.; Candelise, N.; Llorens, F.& Zerr, I.​ (2018)
  In:​Sigurdsson, Einar M.; Calero, Miguel; Gasset, María​ (Eds.), Methods in Molecular Biology Amyloid Proteins pp. 257​-263. ​New York, NY: ​Springer New York. DOI: https://doi.org/10.1007/978-1-4939-7816-8_16 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases​
  Zerr, I.; Schmitz, M.; Karch, A.; Villar‐Piqué, A.; Kanata, E.; Golanska, E. & Díaz‐Lucena, D. et al.​ (2018) 
  Alzheimer's & Dementia, 14(6) pp. 751​-763​.​ DOI: https://doi.org/10.1016/j.jalz.2017.12.008 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie​
  Llorens, F.; Barrio, T.; Correia, Â.; Villar-Piqué, A.; Thüne, K.; Lange, P. & Badiola, J. J. et al.​ (2018) 
  Molecular Neurobiology, 55(11) pp. 8586​-8591​.​ DOI: https://doi.org/10.1007/s12035-018-1014-z 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD​
  Ermann, N.; Lewczuk, P.; Schmitz, M.; Lange, P.; Knipper, T.; Goebel, S. & Kornhuber, J. et al.​ (2018) 
  Annals of Clinical and Translational Neurology, 5(7) pp. 883​-887​.​ DOI: https://doi.org/10.1002/acn3.584 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Variably protease‐sensitive prionopathy presenting within ALS/FTD spectrum​
  Vicente‐Pascual, M.; Rossi, M.; Gámez, J.; Lladó, A.; Valls, J.; Grau‐Rivera, O. & Ávila Polo, R. et al.​ (2018) 
  Annals of Clinical and Translational Neurology, 5(10) pp. 1297​-1302​.​ DOI: https://doi.org/10.1002/acn3.632 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives​
  Kanata, E.; Thüne, K.; Xanthopoulos, K.; Ferrer, I.; Dafou, D.; Zerr, I. & Sklaviadis, T. et al.​ (2018) 
  Frontiers in Aging Neuroscience, 10 art. 220​.​ DOI: https://doi.org/10.3389/fnagi.2018.00220 
  ​Details  DOI  PMID  PMC 

• 2018 | Journal Article | 
  ​ ​Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease​
  Kruse, N.; Heslegrave, A.; Gupta, V.; Foiani, M.; Villar-Piqué, A.; Schmitz, M. & Lehmann, S. et al.​ (2018) 
  Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 10 pp. 461​-470​.​ DOI: https://doi.org/10.1016/j.dadm.2018.06.005 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article
  ​ ​Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease​
  Kanata, E.; Golanska, E.; Villar-Piqué, A.; Karsanidou, A.; Dafou, D.; Xanthopoulos, K. & Schmitz, M. et al.​ (2019) 
  Journal of Clinical Neuroscience, 60 pp. 124​-127​.​ DOI: https://doi.org/10.1016/j.jocn.2018.09.031 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​RNA editing alterations define manifestation of prion diseases​
  Kanata, E.; Llorens, F.; Dafou, D.; Dimitriadis, A.; Thüne, K.; Xanthopoulos, K. & Bekas, N. et al.​ (2019) 
  Proceedings of the National Academy of Sciences, 116(39) pp. 19727​-19735​.​ DOI: https://doi.org/10.1073/pnas.1803521116 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3​
  Llorens, F.; Villar-Piqué, A.; Hermann, P.; Schmitz, M.; Goebel, S.; Waniek, K. & Lachmann, I. et al.​ (2019) 
  Journal of Neurology, 267(2) pp. 543​-550​.​ DOI: https://doi.org/10.1007/s00415-019-09610-8 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD​
  Blennow, K.; Diaz-Lucena, D.; Zetterberg, H.; Villar-Pique, A.; Karch, A.; Vidal, E. & Hermann, P. et al.​ (2019) 
  Journal of Neurology, Neurosurgery & Psychiatry, 90(8) pp. 846​-853​.​ DOI: https://doi.org/10.1136/jnnp-2018-320155 
  ​Details  DOI 

• 2019 | Journal Article | Research Paper
  ​ ​Seeding variability of different alpha synuclein strains in synucleinopathies​
  Candelise, N.; Schmitz, M.; Llorens, F.; Villar‐Piqué, A.; Cramm, M.; Thom, T. & Silva Correia, S. M. et al.​ (2019) 
  Annals of Neurology, 85(5) pp. 691​-703​.​ DOI: https://doi.org/10.1002/ana.25446 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article
  ​ ​An Update on Autophagy in Prion Diseases​
  López-Pérez, Ó.; Badiola, J. J.; Bolea, R.; Ferrer, I.; Llorens, F. & Martín-Burriel, I.​ (2020) 
  Frontiers in Bioengineering and Biotechnology, 8 art. 975​.​ DOI: https://doi.org/10.3389/fbioe.2020.00975 
  ​Details  DOI 

• 2020 | Journal Article
  ​ ​Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis​
  Villar-Pique, A.; Zerr, I. & Llorens, F.​ (2020) 
  Neural Regeneration Research, 15(5) pp. 861​.​ DOI: https://doi.org/10.4103/1673-5374.268901 
  ​Details  DOI 

• 2020 | Journal Article
  ​ ​A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia​
  Diaz-Lucena, D.; Escaramis, G.; Villar-Piqué, A.; Hermann, P.; Schmitz, M.; Varges, D. & Santana, I. et al.​ (2020) 
  Journal of Neurology, 267(9) pp. 2567​-2581​.​ DOI: https://doi.org/10.1007/s00415-020-09870-9 
  ​Details  DOI 

• 2020 | Journal Article
  ​ ​A prognostic model for overall survival in sporadic Creutzfeldt‐Jakob disease​
  Llorens, F.; Rübsamen, N.; Hermann, P.; Schmitz, M.; Villar‐Piqué, A.; Goebel, S. & Karch, A. et al.​ (2020) 
  Alzheimer's & Dementia, 16(10) pp. 1438​-1447​.​ DOI: https://doi.org/10.1002/alz.12133 
  ​Details  DOI 

• 2020 | Journal Article | 
  ​ ​BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers​
  López-Pérez, Ó.; Bernal-Martín, M.; Hernaiz, A.; Llorens, F.; Betancor, M.; Otero, A. & Toivonen, J. M. et al.​ (2020) 
  Biomolecules, 10(5).​ DOI: https://doi.org/10.3390/biom10050706 
  ​Details  DOI 

• 2021 | Journal Article
  ​ ​Validation of Plasma Neurofilament Light Chain as a Marker for α‐Synucleinopathies​
  Schmitz, M.; Canaslan, S.; Villar‐Piqué, A.; Gmitterová, K.; Varges, D.; Lingor, P. & Llorens, F. et al.​ (2021) 
  Movement Disorders, art. mds.28724​.​ DOI: https://doi.org/10.1002/mds.28724 
  ​Details  DOI 

• 2021 | Journal Article | Research Paper | 
  ​ ​Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies​
  Canaslan, S.; Schmitz, M.; Villar-Piqué, A.; Maass, F.; Gmitterová, K.; Varges, D. & Lingor, P. et al.​ (2021) 
  Frontiers in Aging Neuroscience, 13.​ DOI: https://doi.org/10.3389/fnagi.2021.717930 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​TREM2 expression in the brain and biological fluids in prion diseases​
  Diaz-Lucena, D.; Kruse, N.; Thüne, K.; Schmitz, M.; Villar-Piqué, A.; da Cunha, J. E. G. & Hermann, P. et al.​ (2021) 
  Acta Neuropathologica, 141(6) pp. 841​-859​.​ DOI: https://doi.org/10.1007/s00401-021-02296-1 
  ​Details  DOI 

• 2021 | Journal Article
  ​ ​Ecto-GPR37: a potential biomarker for Parkinson’s disease​
  Morató, X.; Garcia-Esparcia, P.; Argerich, J.; Llorens, F.; Zerr, I.; Paslawski, W. & Borràs, E. et al.​ (2021) 
  Translational Neurodegeneration, 10(1).​ DOI: https://doi.org/10.1186/s40035-021-00232-7 
  ​Details  DOI 

• 2021 | Journal Article | Research Paper | 
  ​ ​Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo​
  Thom, T.; Schmitz, M.; Fischer, A.; Correia, A.; Correia, S.; Llorens, F. & Pique, A. et al.​ (2021) 
  Movement Disorders, 37(1) art. mds.28774​.​ DOI: https://doi.org/10.1002/mds.28774 
  ​Details  DOI  PMID  PMC 

Researcher

Sort

Items per Page